DOI QR코드

DOI QR Code

The Effects of Ganoderma Lucidum Pharmacopuncture and Moxibustion (Wang-tteum) on Abdominal Obesity: Case Report

영지약침과 왕뜸 복합치료의 복부비만 개선사례: 증례보고

  • Park, Soo Ah (Department of Acupuncture and Moxibustion Medicine, Samse Korean Medical Hospital) ;
  • Lee, Heun Ju (Department of Acupuncture and Moxibustion Medicine, Samse Korean Medical Hospital) ;
  • Baek, Ji-Yeong (Department of Acupuncture and Moxibustion Medicine, Samse Korean Medical Hospital) ;
  • Son, Kyung-Woo (Department of Internal Medicine of Korean Medicine, Samse Korean Medical Hospital) ;
  • Lim, Kyeong-Tae (Department of Rehabilitation Medicine of Korean Medicine, Pusan National University Korean Medicine Hospital)
  • 박수아 (삼세한방병원 침구의학과) ;
  • 이흔주 (삼세한방병원 침구의학과) ;
  • 백지영 (삼세한방병원 침구의학과) ;
  • 손경우 (삼세한방병원 한방내과) ;
  • 임경태 (부산대학교한방병원 한방재활의학과)
  • Received : 2016.03.12
  • Accepted : 2016.05.30
  • Published : 2016.06.30

Abstract

This study was conducted to investigate the effects of Ganoderma lucidum pharmacopuncture and moxibustion on abdominal obesity. Five women with abdominal obesity were treated 6 times in 2 weeks with Ganoderma lucidum pharmacopuncture on abdominal fat followed by 30 minutes of moxibustion on abdominal area. Before treatment and after 6 treatments were finished, body weight, body mass index, body fat mass, waist circumference, hip circumference and waist-hip ratio were measured. After all treatments, all average measured values were reduced. Body weight and body mass index were reduced by 0.34 kg and $0.46kg/m^2$ respectively. Also, waist circumference and waist-hip ratio were reduced by 4.52 cm and 0.04 respectively. We suppose combined therapy of Ganoderma lucidum pharmacopuncture and moxibustion might be a time-effective treatment for abdominal obesity.

5명의 복부비만 환자에게 주 3회, 총 6회의 영지약침과 왕뜸요법의 복합치료를 실시하였다. 그 결과 복부둘레와 체지방량의 감소를 확인할 수 있었다.

Keywords

References

  1. The Korean Academy of Oriental Rehabiltation Medicine. Oriental rehabiltation medicine. Seoul : Gunja. 2011 : 350-76.
  2. Despres JP. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J. 2006 ; 8 Suppl B : B4-12. https://doi.org/10.1093/eurheartj/sul002
  3. World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation; 2008 Dec 8-11; Geneva, Switzerland. Geneva : WHO Press. 2011.
  4. Jeong SY. Oriental medicine for abdominal obesity: a systematic review. Master's dissertation. Pocheon: CHA University. 2013.
  5. Korean Acupuncture and Moxibustion Medicine Society. The acupuncture and moxibustion. Seoul : Jipmoondang. 2008 : 408.
  6. Shin MS. A case series: the effects of cultivated wild ginseng pharmacopuncture and thread implantation therapy on abdominal obesity. J Korean Med Obes Res. 2013 ; 13(1) : 46-50.
  7. Roh SS, Kim JS, Yim SC. The efficacy of eriobotryae folium pharmacopuncture on local fat of high fat diet induced obesity mice. Acupuncture. 2013 ; 30(3) : 15-25.
  8. Shin SU, Choi YM, Shim WJ, Lee HC, Kim KS. Effects of high frequency therapy on localized obesity. J Korean Soc Study Obes. 2006 ; 6(2) : 75-83.
  9. Kim MW, Song YK, Lim HH. Study of experimentations and clinical trials' trends for obesity treatment using pharmacupuncture. J Korean Soc Study Obes. 2011 ; 11(1) : 47-60.
  10. Jeong BS. Hyangyak dictionary (botanical). Seoul : Yeonglimsa. 2003 : 33-4.
  11. Wang SY, Hsu ML, Hsu HC, Lee SS, Shiao MS, Ho CK. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. J Cancer. 1997 ; 70(6) : 699-705.
  12. Jang SH, Yoon HM, Kim BH, Jang KJ, Kim CH. Effect of Ganoderma lucidum pharmacopuncture on chronic liver injury in rats. Acupuncture. 2015 ; 32(1) : 13-22. https://doi.org/10.13045/acupunct.2015002
  13. Seto SW, Lam TY, Tam HL, Au ALS, Chan SW, Wu JH, et al. Novel hypoglycemic effects of Ganoderma lucidum waterextract in obese/diabetic (+db/+db) mice. Phytomedicine. 2009 ; 16(5) : 426-36. https://doi.org/10.1016/j.phymed.2008.10.004
  14. Lee CW, Yoon HM, Kang KH. The effects of Ganoderma lucidum herba pharmacopuncture on 3T3-L1 preadipocyte differentiation. J Pharmacopunct. 2008 ; 11(3) : 47-53. https://doi.org/10.3831/KPI.2008.11.3.047
  15. Lee CW, Yoon HM, Kang KH. Adipocyte-related genes and transcription factors were affected by Ganoderma lucidum during 3t3-l1 differentiation. J Pharmacopunct. 2009 ; 12(2) : 13-20. https://doi.org/10.3831/KPI.2009.12.2.013
  16. Lee SM, Yoon YD, Baek JH, Hyun KR, Kang HR. The influence of major health hazard factors on socio-economic cost and regulation policy efficacy assesment [Internet]. Seoul: National Health Insurance Service; 2015 [cited 2016 Mar 7]. Available from: http://www.nhis.or.kr/bbs7/boards/B0069/16002.
  17. Jo S, Song, Hong K. Literature review study of lipolysis effect of moxibustion treatment. Acupuncture. 2012 ; 29(5) : 119-26. https://doi.org/10.13045/kamms.2012092
  18. WHO expert consultation. Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet. 2004 ; 363(9403) : 157-63. https://doi.org/10.1016/S0140-6736(03)15268-3
  19. Lee S, Park HS, Kim SM, Kwon HS, Kim DY, Kim DJ, et al. Cut-off points of waist circumference for defining abdominal obesity in the Korean population. Korean J Obes. 2006 ; 15(1) : 1-9.

Cited by

  1. CARE (CAse REport) 지침에 의한 한방비만학회지 증례 논문에 대한 보고의 질 평가: 2013년~2018년 증례보고를 중심으로 vol.18, pp.2, 2018, https://doi.org/10.15429/jkomor.2018.18.2.144
  2. 최근 10년간 한방비만학회지의 연구동향 분석: 2010-2019년 한방비만학회지 게재논문을 중심으로 vol.20, pp.2, 2016, https://doi.org/10.15429/jkomor.2020.20.2.149